Peter Gillette

2.4k total citations · 2 hit papers
42 papers, 2.0k citations indexed

About

Peter Gillette is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, Peter Gillette has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 13 papers in Hematology and 8 papers in Physiology. Recurrent topics in Peter Gillette's work include Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (11 papers) and Erythrocyte Function and Pathophysiology (8 papers). Peter Gillette is often cited by papers focused on Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (11 papers) and Erythrocyte Function and Pathophysiology (8 papers). Peter Gillette collaborates with scholars based in United States and United Kingdom. Peter Gillette's co-authors include C. A. Reindorf, Donald Brambilla, Oswaldo Castro, Attallah Kappas, Anthony Cerami, Chull S. Song, Arleen B. Rifkind, James M. Manning, T. F. Gallagher and H. Leon Bradlow and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter Gillette

42 papers receiving 1.8k citations

Hit Papers

The acute chest syndrome in sickle cell disease: incidenc... 1994 2026 2004 2015 1994 1994 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Gillette United States 18 1.4k 1.1k 451 327 299 42 2.0k
Ada Goldfarb Israel 27 1.2k 0.9× 1.0k 1.0× 210 0.5× 281 0.9× 307 1.0× 49 2.0k
A. D. Stephens United Kingdom 20 671 0.5× 503 0.5× 288 0.6× 198 0.6× 122 0.4× 47 1.3k
Eduard J. van Beers Netherlands 25 940 0.7× 783 0.7× 248 0.5× 284 0.9× 619 2.1× 109 1.6k
Irene Motta Italy 20 927 0.7× 857 0.8× 201 0.4× 486 1.5× 266 0.9× 72 1.8k
Thomas F. Necheles United States 18 300 0.2× 311 0.3× 287 0.6× 186 0.6× 269 0.9× 42 985
Robert C. Hartmann United States 23 265 0.2× 476 0.4× 149 0.3× 193 0.6× 181 0.6× 50 1.3k
John‐John B. Schnog Netherlands 24 1.0k 0.7× 757 0.7× 119 0.3× 265 0.8× 280 0.9× 50 1.4k
William B. Castle United States 14 253 0.2× 311 0.3× 146 0.3× 220 0.7× 346 1.2× 30 1.3k
Amira Adly Egypt 18 438 0.3× 420 0.4× 105 0.2× 217 0.7× 187 0.6× 82 1.1k
J. V. Lloyd Australia 29 280 0.2× 1.1k 1.0× 52 0.1× 240 0.7× 107 0.4× 98 2.1k

Countries citing papers authored by Peter Gillette

Since Specialization
Citations

This map shows the geographic impact of Peter Gillette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gillette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gillette more than expected).

Fields of papers citing papers by Peter Gillette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gillette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gillette. The network helps show where Peter Gillette may publish in the future.

Co-authorship network of co-authors of Peter Gillette

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gillette. A scholar is included among the top collaborators of Peter Gillette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gillette. Peter Gillette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinhas, Alexander, Justin Migacz, Vincent Sun, et al.. (2022). Insights into Sickle Cell Disease through the Retinal Microvasculature. SHILAP Revista de lepidopterología. 2(4). 100196–100196. 17 indexed citations
2.
Rosen, Richard B., Justin Migacz, Alexander Pinhas, et al.. (2021). Preferential Vulnerability of Capillary Occlusion in Sickle Cell Retinopathy. Investigative Ophthalmology & Visual Science. 62(11). 12–12. 1 indexed citations
3.
Johnson, Colin A., et al.. (2019). Characterization of microvascular disease in patients with sickle cell disease using nailfold capillaroscopy. Microvascular Research. 125. 103877–103877. 2 indexed citations
4.
Anjum, Fatima, et al.. (2011). Uric Acid as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Sickle Cell Disease. Indian Journal of Hematology and Blood Transfusion. 27(2). 96–100. 6 indexed citations
5.
Zinn, Harry, et al.. (2001). A RARE CASE OF OSTEOMYELITIS OF THE STERNUM IN AN ADULT WITH SICKLE CELL DISEASE. Hemoglobin. 25(1). 111–113. 1 indexed citations
6.
Chalchal, Haji, William Rodino, Iftikhar Ul Haq, et al.. (2001). Impaired venous hemodynamics in a minority of patients with chronic leg ulcers due to sickle cell anemia.. PubMed. 30(4). 277–9. 11 indexed citations
7.
Chalchal, Haji, William Rodino, Inaamul Haq, et al.. (2001). Chronische venöse Insuffizienz in einer Minderzahl von Patienten mit Ulcus cruris infolge einer Sichelzellanämie. VASA. 30(4). 277–279. 10 indexed citations
8.
Steinberg, Martin H., Henry Hsu, R L Nagel, et al.. (1995). Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. American Journal of Hematology. 48(3). 175–181. 94 indexed citations
9.
Castro, Oswaldo, et al.. (1994). The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 84(2). 643–649. 513 indexed citations breakdown →
10.
Castro, Oswaldo, et al.. (1994). The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 84(2). 643–649. 550 indexed citations breakdown →
12.
Rieder, Ronald F., Surinder Safaya, Peter Gillette, et al.. (1991). Effect of β‐Globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia. American Journal of Hematology. 36(3). 184–189. 38 indexed citations
13.
Peterson, Charles M., et al.. (1974). STUDIES WITH INTRAVENOUS SODIUM CYANATE IN PATIENTS WITH SICKLE CELL ANEMIA. Journal of Pharmacology and Experimental Therapeutics. 189(3). 577–584. 6 indexed citations
14.
Gillette, Peter, et al.. (1974). Sodium Cyanate as a Potential Treatment for Sickle-Cell Disease. New England Journal of Medicine. 290(12). 654–660. 56 indexed citations
15.
Bradlow, H. Leon, Peter Gillette, T. F. Gallagher, & Attallah Kappas. (1973). STUDIES IN PORPHYRIA. The Journal of Experimental Medicine. 138(4). 754–763. 33 indexed citations
16.
Cerami, Anthony, et al.. (1973). PHARMACOLOGY OF CYANATE. I. GENERAL EFFECTS ON EXPERIMENTAL ANIMALS. Journal of Pharmacology and Experimental Therapeutics. 185(3). 653–666. 54 indexed citations
17.
Jones, Wanda M., et al.. (1973). Carbamylation of the Chains of Hemoglobin S by Cyanate in Vitro and in Vivo. Journal of Biological Chemistry. 248(23). 8052–8056. 37 indexed citations
18.
Kappas, Attallah, H. Leon Bradlow, Peter Gillette, & T. F. Gallagher. (1972). STUDIES IN PORPHYRIA. The Journal of Experimental Medicine. 136(5). 1043–1053. 39 indexed citations
19.
Gillette, Peter, Charles M. Peterson, James M. Manning, & Anthony Cerami. (1972). Preliminary Clinical Trials with Cyanate. Advances in experimental medicine and biology. 28. 261–278. 17 indexed citations
20.
Gillette, Peter, James M. Manning, & Anthony Cerami. (1971). Increased Survival of Sickle-Cell Erythrocytes after Treatment In Vitro with Sodium Cyanate. Proceedings of the National Academy of Sciences. 68(11). 2791–2793. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026